Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05167617Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by Tanta University. Primary endpoint: Clinical Improvement at 6 months. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05167617.